We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+7.26%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$417M
AUM Growth
+$46.4M
Cap. Flow
+$20M
Cap. Flow %
4.81%
Top 10 Hldgs %
59.21%
Holding
39
New
6
Increased
14
Reduced
10
Closed
8

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$22.4M
2
BAX icon
Baxter International
BAX
+$16.2M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$12.6M
4
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$10.2M
5
PDCO
Patterson Companies, Inc.
PDCO
+$8.99M

Top Sells

Rank Stock Value
1
FRX
FOREST LABORATORIES INC
FRX
+$26.4M
2
BSX icon
Boston Scientific
BSX
+$7.67M
3
MASI
Masimo
MASI
+$7.11M
4
STJ
St Jude Medical
STJ
+$6.57M
5
CAH icon
Cardinal Health
CAH
+$6.26M

Sector Composition

Rank Sector Weight
1 Healthcare 85.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.05T
$46.3M 11.11%
786,947
-18,000
-2% -$1M
BAX icon
2
Baxter International
BAX
$11.7B
$42.9M 10.28%
1,072,751
+432,819
+68% +$16.2M
BSX icon
3
Boston Scientific
BSX
$65.4B
$27.2M 6.52%
2,010,800
-584,000
-23% -$7.67M
EW icon
4
Edwards Lifesciences
EW
$49.4B
$23.3M 5.58%
1,881,600
+579,600
+45% +$6.69M
ABBV icon
5
AbbVie
ABBV
$450B
$22.8M 5.46%
+443,400
New +$22.4M
TEVA icon
6
Teva Pharmaceuticals
TEVA
$37.3B
$20.6M 4.94%
390,000
+92,300
+31% +$4.27M
JNJ icon
7
Johnson & Johnson
JNJ
$609B
$18.4M 4.42%
187,750
-18,800
-9% -$1.74M
RVTY icon
8
Revvity
RVTY
$12.3B
$16M 3.85%
355,960
+72,800
+26% +$3.2M
DGX icon
9
Quest Diagnostics
DGX
$23.3B
$15M 3.6%
259,128
+106,000
+69% +$5.68M
CAH icon
10
Cardinal Health
CAH
$53.5B
$14.4M 3.45%
205,700
-90,000
-30% -$6.26M
THOR
11
DELISTED
THORATEC CORPORATION
THOR
$13.9M 3.33%
387,300
+117,200
+43% +$4.2M
IRWD icon
12
Ironwood Pharmaceuticals
IRWD
$635M
$12.7M 3.03%
1,226,227
+340,290
+38% +$3.83M
WCG
13
DELISTED
Wellcare Health Plans, Inc.
WCG
$12.4M 2.97%
+194,700
New +$12.6M
CBST
14
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$12.2M 2.92%
166,390
-9,700
-6% -$723K
UNH icon
15
UnitedHealth
UNH
$387B
$12M 2.87%
145,800
+4,100
+3% +$309K
A icon
16
Agilent Technologies
A
$37.1B
$11.7M 2.82%
293,580
-102,054
-26% -$4.2M
LPNT
17
DELISTED
LifePoint Health, Inc.
LPNT
$11.1M 2.65%
202,900
-13,100
-6% -$700K
RMD icon
18
ResMed
RMD
$28.9B
$9.88M 2.37%
221,000
+70,000
+46% +$3.14M
ACOR
19
DELISTED
Acorda Therapeutics
ACOR
$9.5M 2.28%
2,089
+1,131
+118% +$4.57M
VOLC
20
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$9.38M 2.25%
+475,900
New +$10.2M
PDCO
21
DELISTED
Patterson Companies, Inc.
PDCO
$9.19M 2.2%
+220,165
New +$8.99M
AUXL
22
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$7.72M 1.85%
284,020
-178,484
-39% -$4.74M
BIO icon
23
Bio-Rad Laboratories Class A
BIO
$8.15B
$7.67M 1.84%
59,900
+1,700
+3% +$218K
THC icon
24
Tenet Healthcare
THC
$16.8B
$7.45M 1.79%
174,000
+95,000
+120% +$4.19M
ESRX
25
DELISTED
Express Scripts Holding Company
ESRX
$6.51M 1.56%
86,700
-60,100
-41% -$4.5M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q1 2014 Portfolio in Review

As of Q1 2014, Sector Gamma AS held 39 positions worth $417M, up 13% from $371M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Sector Gamma AS deployed $20M of net new capital in Q1 2014, opening 6 new positions and adding to 14 existing holdings. Its largest new stake was AbbVie: 443,400 shares worth $22.8M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 88% a quarter earlier.

On the sell side, the largest reduction was Boston Scientific, an estimated $7.67M trimmed.

  • Sector Gamma AS's largest Q1 2014 buy was AbbVie: 443,400 shares worth $22.8M.
  • Sector Gamma AS added most to Baxter International in Q1 2014, an estimated $16.2M increase.
  • Sector Gamma AS's biggest Q1 2014 reduction was Boston Scientific, cutting an estimated $7.67M.
  • Sector Gamma AS fully exited FOREST LABORATORIES INC in Q1 2014, selling an estimated $26.4M.
  • Sector Gamma AS's ten largest holdings make up 59% of its $417M portfolio in Q1 2014.
  • Sector Gamma AS opened 6 new positions and closed 8 in Q1 2014.
  • Sector Gamma AS's portfolio value rose 13% quarter-over-quarter to $417M.

Based on Sector Gamma AS's 13F filing for Q1 2014, filed 9 May 2014.